Re: OTC Expert & Grey Market Restrictions
in response to
by
...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Message: OTC Expert & Grey Market Restrictions
Someone is testing the waters. At least we know ZHCLF is still trading.
| ZHCLF(ZENITH CAP CORP) | Real-time | ||
|
$0.075
|
Bid:
$0.000
|
Ask:
|
$0.000
|
|
|
Bid Lots:
0
|
Ask Lots:
|
0
|
|
|
High:
$0.075
|
Low:
|
$0.075
|
|
Last trade:
|
Vol:
500
|
Tick:
|
-
|
|
10:27 ET
|
Koo
New Message
Please
login
to post a reply